- Real-Word Evidence: a new standard of medical research?2017 | Second Faculty of Medicine
- Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic2024 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine
- Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe2020 | First Faculty of Medicine
- Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence2023 | First Faculty of Medicine
- Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence2020 | Faculty of Medicine in Pilsen
- How does the financial market update beliefs about the real economy? Evidence from the oil market2021 | Faculty of Social Sciences, Faculty of Mathematics and Physics, Centre for Economic Research and Graduate Education
- Lenalidomide maintenance in R2-ISS stratified multiple myeloma patients - real world evidencePublication without faculty affiliation
- Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Real-world evidence on prognostic value of minimal residual disease in multiple myeloma: Czech experiencePublication without faculty affiliation
- Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic2021 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine
- Potřebujeme studie z reálné klinické praxe?2018 | Second Faculty of Medicine
- Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results2022 | First Faculty of Medicine
- Deintensification to a fixed mixture of insulin glargine and lixisenatide as a way to modern antidiabetic therapy in patients with type 2 diabetes mellitus2020 | First Faculty of Medicine
- MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence2018 | Faculty of Medicine in Pilsen
- Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic2022 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
- Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data2022 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
- Real-world evidence on the dosing and safety of C.E.R.A. in pediatric dialysis patients: findings from the International Pediatric Dialysis Network registries2024 | Second Faculty of Medicine
- Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic2022 | First Faculty of Medicine
- Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men2021 | First Faculty of Medicine, Central Library of Charles University
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity2023 | First Faculty of Medicine
- Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs2019 | First Faculty of Medicine
- Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology2023 | First Faculty of Medicine
- Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries2023 | First Faculty of Medicine
- Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration2023 | First Faculty of Medicine
- Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study2023 | First Faculty of Medicine
- Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community2023 | First Faculty of Medicine